APA (7th ed.) Citation

Li, X., Lu, J., Zhang, L., Luo, Y., Zhao, Z., & Li, M. (2020). Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer. Translational Oncology, 13(2), 321. https://doi.org/10.1016/j.tranon.2019.11.007

Chicago Style (17th ed.) Citation

Li, Xuelu, Jiawei Lu, Lanxin Zhang, Yaoting Luo, Zuowei Zhao, and Man Li. "Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer." Translational Oncology 13, no. 2 (2020): 321. https://doi.org/10.1016/j.tranon.2019.11.007.

MLA (9th ed.) Citation

Li, Xuelu, et al. "Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer." Translational Oncology, vol. 13, no. 2, 2020, p. 321, https://doi.org/10.1016/j.tranon.2019.11.007.